Our expert for hiPSC-derived cardiac cells, as well as cell-based assays & services for drug safety and efficacy screenings
In order to translate an in vitro cardiac cellular model into the correct clinical interpretation of assay read-outs, a fully functional and validated model is needed.
Ncardia iPSC-derived cardiomyocytes are used in the assessment of safety pharmacology at the pre-clinical stage as well as drug efficacy testing. You can find our cardiomyocytes available as cryopreserved cells, or ready-to-go for specific applications in a CardioPlate™.
The Cor.4U, vCor.4U and FibroCor.4U and Cor.4U CardioPlate products have been discontinued. Please address questions to firstname.lastname@example.org or contact your local Ncardia sales representative.
Human iPSC-derived cardiomyocytes with a fully functional, ventricular phenotype for use in drug discovery and development. They are acquired without genetic modifications, and cultured in a well-defined, serum-free culture medium that enhances their functionality and maturity.